Calidi Biotherapeutics director Corazon “Corsee” Sanders files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Calidi Biotherapeutics director Corazon 'Corsee' Sanders filed an initial Form 3 beneficial ownership statement on June 29, reporting a transaction that occurred on June 17. The filing was published via EDGAR by the U.S. Securities and Exchange Commission.
- Calidi Biotherapeutics director Corazon (Corsee) D. Sanders filed an initial Form 3 on June 29 tied to a June 17 reportable event. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031118), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here